Skip to main content

Table 1 Baseline patient characteristics

From: Where is the exact origin of narrow premature ventricular contractions manifesting qR in inferior wall leads?

Patient Age (y) Sex PVC count (number/24 h) Symptoms Symptom duration (M) AADs used Comorbidities LVEF (%) LVEDd (mm)
1 38 M 11026 palpitation 23 Beta-blocker,
Propafenone
none 65 58
2 47 F 20348 palpitation 14 Beta-blocker none 59 49
3 27 F 18265 palpitation 18 Beta-blocker none 68 45
4 35 F 13529 palpitation 9 Beta-blocker,
Mexiletine
none 67 44
5 24 M 22057 palpitation 22 Beta-blocker,
Propafenone
none 66 47
6 41 M 32784 palpitation 38 Beta-blocker,
Propafenone
none 69 48
7 21 F 12683 palpitation 16 Beta-blocker,
Propafenone
none 66 46
8 27 F 21522 palpitation 32 Beta-blocker none 63 49
9 15 M 32657 palpitation,
chest pain
26 Beta-blocker,
Amiodarone
none 62 43
10 62 M 32158 Palpitation
chest pain
39 Beta-blocker,
Mexiletine,
hypertension 66 41
11 34 F 26712 Palpitation 48 Beta-blocker none 67 47
12 28 M 15336 Palpitation 18 Beta-blocker,
Mexiletine
none 65 48
13 14 F 28637 Palpitation,
chest pain
46 Beta-blocker,
Propafenone
none 66 42
14 42 F 24512 Palpitation 13 Beta-blocker none 59 47
15 13 M 24104 palpitation 16 Beta-blocker,
Propafenone
none 65 51
16 22 F 16248 palpitation 10 Beta-blocker none 58 46
17 65 F 16412 palpitation 16 Beta-blocker,
Amiodarone
diabetes 62 47
18 37 M 20119 palpitation 6 Beta-blocker none 62 46
19 29 M SVT palpitation 18 Beta-blocker none 65 46
20 39 F 13008 palpitation,
chest pain
6 Beta-blocker,
Propafenone
none 62 48
21 25 M 20116 palpitation 26 Beta-blocker none 65 49
22 36 M 16551 Palpitation 13 Beta-blocker,
Propafenone
none 66 47
23 44 F 9807 palpitation,
chest pain
28 Beta-blocker,
Propafenone
none 68 47
24 58 M 16579 Palpitation 22 Beta-blocker,
Propafenone
hypertension 66 49
25 33 F 22172 Palpitation 24 Beta-blocker,
Propafenone
none 65 48
26 54 F 18613 Palpitation 20 - hypertension 42 61
27 32 M 24007 palpitation 16 Beta-blocker,
Amiodarone
none 65 46
28 27 F 21038 palpitation 5 Beta-blocker,
Propafenone
none 63 47
29 29 M 15416 palpitation 22 Beta-blocker none 67 48
30 32 F 19478 palpitation 24 Beta-blocker,
Propafenone, Mexiletine
none 64 47
31 34 F 22342 palpitation 2 Beta-blocker,
Propafenone,
none 68 46
32 33 F 12763 palpitation 6 Beta-blocker,
Propafenone,
none 68 47
33 24 F 12913 palpitation 5 Beta-blocker,
Propafenone,
none 70 46
34 22 F 15692 palpitation 24 Beta-blocker,
Propafenone,
none 68 45
35 62 M 26314 palpitation 12 Beta-blocker none 66 50
36 50 F 15213 palpitation 16 Beta-blocker,
Propafenone,
none 65 48
37 24 F 16327 palpitation 38 Beta-blocker,
Propafenone,
none 66 46
38 40 F 18706 palpitation 26 Beta-blocker,
Propafenone,
none 66 48
39 50 M 20522 palpitation 32 Beta-blocker,
Propafenone,
none 65 48
40 38 M 12637 palpitation 16 Beta-blocker,
Propafenone,
none 68 46
Mean ± SD 33.53 ± 12.48   20231 ± 6102   20.08 ± 11.28    64.88 ± 2.76 46.69 ± 2.28
  1. Annotation:Y years, M Months, AADs antiarrhythmic drugs, LVEF left ventricular ejection fraction, LVEDd left ventricular end-diastolic internal diameter